![Emily Anne Scraggs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emily Anne Scraggs
Directeur/Membre du Conseil chez Talisman Therapeutics Ltd.
Postes actifs de Emily Anne Scraggs
Sociétés | Poste | Début | Fin |
---|---|---|---|
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | - | - |
Historique de carrière de Emily Anne Scraggs
Anciens postes connus de Emily Anne Scraggs
Sociétés | Poste | Début | Fin |
---|---|---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Directeur/Membre du Conseil | 07/01/2016 | - |
Fondateur | 07/01/2016 | - |
Statistiques
Internationale
Royaume-Uni | 3 |
Opérationnelle
Director/Board Member | 2 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Emily Anne Scraggs
- Expérience